ArticleHealth economics2026
Vaccination and Risk Aversion: Evidence From a Flu Vaccination Campaign.
Article in Health economics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The impact of free influenza vaccination schemes on vaccine uptake among older adults in Europe, 2019-2020.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Vaccination and Risk Aversion: Evidence From a Flu Vaccination Campaign.Health economics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We examine the causal effect of a French flu vaccination campaign on vaccination behavior. Individuals aged 65 and over receive an invitation letter with a voucher for a free flu shot, while those who are not eligible have to cover the costs themselves. Using a Fuzzy Regression Discontinuity Design, we find that receiving the invitation letter with the voucher leads to a significant increase in the likelihood of getting vaccinated. This effect is driven by individuals who are risk-averse. As illustrated in our theoretical model, for them, the costs of influenza infection outweigh the costs of the vaccine's side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.